Literature DB >> 17053985

Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models.

Anasuya Hazra1, Wojciech Krzyzanski, William J Jusko.   

Abstract

Precursor-dependent indirect response (PDIDR) models may describe the tolerance and rebound phenomenon observed for many pharmacodynamic responses where these characteristics are manifested due to the depletion or accumulation of a physiological precursor or cofactor pool responsible for generating drug effects. The purpose of this report is to extend the concepts and applications of these models and to approximate responses and limiting conditions for very large doses of drugs. Asymptotic analysis was performed for qualitative determination of various parameters, such as maximum response (Rmax) and rebound (RBmax), time to maximum response and rebound (TRmax and TRBmax), and area under the effect and rebound curve (ABEC and ABRC) for large doses. Computer simulations were performed to assess the role of dose for both cases where drugs act either by depleting (Model V) or by blocking (Model VI) the endogenous precursor. Simulations showed that Rmax, RBmax, TRBmax, ABEC and ABRC increase with dose, eventually reaching a plateau when Dose/V is very large compared to the efficacy parameters (SC50 or IC50) of the drug. However, TRmax either increased or decreased with dose depending on various system and drug parameters. The limits for these parameters at large doses qualitatively determined by asymptotic analysis closely approximated the plateaus observed from the simulated curves. At large doses, the drug response could be approximated by a Bateman-like function for both Models V and VI. Qualitative analyses along with simulation studies provide a fundamental basis for understanding the temporal aspects of the PDIDR models especially at large doses to describe the tolerance and rebound phenomenon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053985     DOI: 10.1007/s10928-006-9030-4

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  17 in total

1.  Mathematical formalism and characteristics of four basic models of indirect pharmacodynamic responses for drug infusions.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

2.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

Review 3.  Blood pressure control--special role of the kidneys and body fluids.

Authors:  A C Guyton
Journal:  Science       Date:  1991-06-28       Impact factor: 47.728

4.  A dynamical systems analysis of the indirect response model with special emphasis on time to peak response.

Authors:  Lambertus A Peletier; Johan Gabrielsson; Jacintha den Haag
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

5.  Corticosteroid effects in skeletal muscle: gene induction/receptor autoregulation.

Authors:  L I McKay; D C DuBois; Y N Sun; R R Almon; W J Jusko
Journal:  Muscle Nerve       Date:  1997-10       Impact factor: 3.217

6.  Characterization of four basic models of indirect pharmacodynamic responses.

Authors:  A Sharma; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

Review 7.  Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model.

Authors:  D R Sibley; R J Lefkowitz
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

8.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

9.  A model eliciting transient responses.

Authors:  E B Ekblad; V Licko
Journal:  Am J Physiol       Date:  1984-01

10.  Prolactin release after remoxipride by an integrated pharmacokinetic-pharmacodynamic model with intra- and interindividual aspects.

Authors:  G Movin-Osswald; M Hammarlund-Udenaes
Journal:  J Pharmacol Exp Ther       Date:  1995-08       Impact factor: 4.030

View more
  7 in total

1.  Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.

Authors:  Sihem Ait-Oudhia; Jean-Michel Scherrmann; Wojciech Krzyzanski
Journal:  J Pharmacol Exp Ther       Date:  2010-05-25       Impact factor: 4.030

2.  Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models.

Authors:  Xu Steven Xu; Hui Wang; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-03-31       Impact factor: 2.745

Review 3.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

4.  Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis.

Authors:  Chuanpu Hu; Philippe O Szapary; Newman Yeilding; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-02-13       Impact factor: 2.745

5.  Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.

Authors:  Siddharth Sukumaran; William J Jusko; Debra C DuBois; Richard R Almon
Journal:  J Pharmacol Exp Ther       Date:  2011-03-11       Impact factor: 4.030

6.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08

7.  Understanding the Behavior of Systems Pharmacology Models Using Mathematical Analysis of Differential Equations: Prolactin Modeling as a Case Study.

Authors:  S Bakshi; E C de Lange; P H van der Graaf; M Danhof; L A Peletier
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.